More Vitura Health Limited news
Vitura Health LimitedASX: VIT

ASX Appendix 4D

Feb 25, 2024 at 9:57 PM EST · Issued by Vitura Health Limited

Filed with ASX · Feb 25, 2024 at 9:57 PM EST

On 6ix: 6ix.com/news/asx-appendix-4d-1

Vitura Health Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Vitura Health Limited on 6ix

In the deck

  • Vitura Health — H1 FY2024 Earnings Presentation23 slidesFeb 26, 2024

Story so far

  • Appendix 4E Preliminary Final ReportAug 23, 2023
  • Quarterly Activities/Appendix 4C Cash Flow ReportOct 19, 2022
  • Monthly Activities/Appendix 4C Cash Flow ReportJul 29, 2021

Earlier from Vitura Health

  • Agreement executed with WholeLife Pharmacy GroupJan 21, 2024
  • Vitura adds smoking cessation product verticalJan 9, 2024
  • Canview Services Agreement not to be extendedDec 26, 2023
  • Sale of 2 millionth unit through CanViewDec 10, 2023
  • Materials for 2023 Annual General MeetingNov 27, 2023

Later from Vitura Health

  • Investor webinar and presentationFeb 25, 2024
  • First supply of PsilocybinMar 17, 2024
  • CEO transitionApr 21, 2024
  • Pause in TradingApr 22, 2024
  • Services Agreement with Code4 CannabisApr 22, 2024
All Vitura Health news releases↗

Follow Vitura Health into a list and get an email when it puts out news.

Follow Vitura Health
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer